Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Biogen
This study was previously posted by Pfizer, Inc. Sponsorship of the trial was transferred to Biogen.
Age
50–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects must have a current diagnosis of age related sensorineural hearing loss in the range of 30-60 dB, averaged over 2 and 4 kHz in at least one ear.
Subjects must have symmetric hearing loss
Subjects who can read, speak and comprehend English.
You may not be if
Subjects who have a history of sudden hearing loss and history or diagnosis of rapidly progressive idiopathic hearing loss
Subjects who have hearing disorders other than age related sensorineural hearing loss
Subjects with moderate or greater tinnitus
Pregnant females; breastfeeding females; females of childbearing potential
Clareo Health | A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
